Post-Pandemic: Space and time

Optos’s ultra-widefield (UWF) retinal imaging technology allows the company’s devices to produce 200° UWF Optomap images that document 82% of the retina in a single capture. The Optos range of devices that employ UWF imaging includes Silverstone, Monaco, California and Daytona. The company says Optos imaging is proven to improve practice efficiency resulting in less waiting room time. In addition, Optomap images can be captured from a safe distance with no close face-to-face interaction.

According to Optos, more than 20,000 Optos devices are in use worldwide with Optomap imaging used by relevant health professionals to diagnose and manage hundreds of eye diseases, including detachments, age-related macular degeneration (AMD) and diabetic eye disease. Optomap has also helped the detection of early-stage ocular cancers and cardiovascular disease resulting in life-saving treatments.